Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States-Reference-Cited by-同舟云学术

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States

Published:2024-01-31 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

La Elizabeth M.¹,Bunniran Su²,Garbinsky Diana²,Reynolds Maria²,Schwab Phil²,Poston Sara¹,Harrington Lauriane³

Affiliation:

1. GSK, Philadelphia, PA, USA

2. RTI Health Solutions, Research Triangle Park, NC, USA

3. GSK, Wavre, Belgium

Funder

GlaxoSmithKline Biologicals

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2303796

Reference23 articles.

1. Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

2. Centers for Disease Control and Prevention. People at high risk for severe RSV infection. [accessed 2022 Aug 1]. https://www.cdc.gov/rsv/high-risk/index.html.

3. Centers for Disease Control and Prevention. RSV in older adults and adults with chronic medical conditions. [accessed 2022 Dec 1]. https://www.cdc.gov/rsv/high-risk/older-adults.html.

4. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023

5. Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and prognostic impact of respiratory syncytial virus among hospitalized patients with acute respiratory symptoms during July–December 2023 in Japan;Journal of Infection and Chemotherapy;2024-10

2. Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel;Human Vaccines & Immunotherapeutics;2024-08-19